Dynamic change of variant allele frequency reveals disease status, clonal evolution and survival in pediatric relapsed B‐cell acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Dynamic change of variant allele frequency reveals disease status, clonal evolution and survival in pediatric relapsed B‐cell acute lymphoblastic leukaemia

Published:2022-05 Issue:5 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Wu Shuiyan¹²,Liu Lixia³,Chu Xinran¹,Zheng Jiajia¹,Chen Zixing⁴,Gao Li¹,Xiao Peifang¹,Lu Jun¹,Ji Qi¹,Ling Jing¹,Cao Shanbo³,Pan Jian⁵,Qin Jiayue³^ORCID,Hu Shaoyan¹^ORCID

Affiliation:

1. Department of Hematology and Oncology Children's Hospital of Soochow University Suzhou China

2. Pediatric Intensive Care Unit Children's Hospital of Soochow University Suzhou China

3. Department of Medical Affairs Acornmed Biotechnology Co., Ltd. Tianjin China

4. Department of Hematology The First Affiliated Hospital of Soochow University Suzhou China

5. Institute of Pediatric Research Children's Hospital of Soochow University Suzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.892

Reference10 articles.

1. Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)

2. Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy

3. Using circulating tumor DNA to monitor myelodysplastic syndromes status

4. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia

5. Clonal dynamics in pediatric B‐cell precursor acute lymphoblastic leukemia with very early relapse

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia;Clinical and Experimental Medicine;2024-03-28

2. Envita&#8217;s Precision Cancer Care: 35-Fold Improvement in Response Rates;Journal of Cancer Therapy;2024

3. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B-cell acute lymphoblastic leukemia;2023-07-10